health-it is the sole category represented across all 1 tracked stories. NVIDIA is most often covered alongside AI Lung Digital Twin Platform, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 4.3 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about NVIDIA
health-it is the sole category represented across all 1 tracked stories. NVIDIA is most often covered alongside AI Lung Digital Twin Platform, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 4.3 for the same window. At 7, the average consequence score sits above the same-window beat average of 5.9. We currently track 1 Healthcare story that mention NVIDIA, all published on March 16, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering NVIDIA. Shared-story counts are live from our verified record — not editorial picks.
L&T Technology Services has partnered with NVIDIA to launch a groundbreaking AI Lung Digital Twin platform designed to enhance respiratory diagnostics. The platform leverages high-performance AI to create personalized virtual models of patient lungs, enabling more precise treatment simulations and faster clinical decision-making.